secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001356576-25-000020
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus to announce Q1 2025 results and host call on May 6
-----------------------------------------------------------

- Q1 2025 financial results to be reported after market close on Tuesday, May 6, 2025.
- Conference call and webcast at 4:30 p.m. ET on May 6, hosted by CEO Jack Khattar and CFO Tim Dec.
- Participants may pre-register for dial-in; replay will be available for 60 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000020/0001356576-25-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000020/supn-20250423.htm
  HTML page:      https://secwatch.observer/filing/0001356576-25-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer